The Specialty Products division carries a range of 300 generic prescription drugs and self-care products for primary healthcare. The portfolio includes products developed and manufactured by Orion, as well as by Orion’s partners.

Net Sales 2010: EUR 298.6 million 

Specialty Products is one of  the two strategic pillars of Orion's pharmaceutical business, in addition to Proprietary Products. The diverse and competitive Specialty Products portfolio drives steady growth and helps Orion to expand and achieve its growth targets.

Orion has developed most of its prescription drugs and self-care products independently. The company also manufactures the majority of its products. Orion’s most familiar products for Finns are Burana®, Finland’s best-selling painkiller, Aqualan® creams and Multivita® vitamins. Customers include doctors, pharmacies, hospitals and consumers, and the market area covers the entire Europe. Orion’s main market areas are Finland, the Nordic countries and Eastern Europe including Russia.

Read about generic prescription drugs and self-care products here